|
|
||||||||
The Journal of Immunology, Vol 153, Issue 6 2544-2553, Copyright © 1994 by American Association of Immunologists
ARTICLES |
GS Hui, WL Gosnell, SE Case, C Hashiro, C Nikaido, A Hashimoto and DC Kaslow
Department of Tropical Medicine, University of Hawaii, Honolulu 96816.
The immunogenicity of the C-terminal 19-kDa fragment of Plasmodium falciparum MSP1 expressed in yeast as a nonfusion product, YMSP1(19), was studied. Immunization with YMSP1(19) in rabbits induced high titers of Abs specific for native conformational epitopes on parasite MSP1. In mice, immunogenicity was dependent on the mouse strain and the adjuvant formulation. This suggests that different adjuvants may alter the immunogenicity of MSP1(19) in a genetically diverse population. Although YMSP1(19) induced anti-MSP1 Abs, they did not inhibit in vitro parasite growth. This contrasts with the strong inhibitory activities of Abs produced against a recombinant MSP1(42) (BVp42), which contains the entire MSP1(19) coding sequence. Further analyses showed that YMSP1(19) was the target of the inhibitory, anti-BVp42 Abs because YMSP1(19) could completely block binding of anti-BVp42 Abs to parasite MSP1 or BVp42. Moreover, depletion of YMSP1(19)-specific Abs completely abolished the parasite inhibitory activities of anti-BVp42 sera. Anti- YMSP1(19) sera did not block the inhibitory activities of anti-BVp42 sera, suggesting that inhibitory epitopes were not in close structural proximity with noninhibitory epitopes. The finding that YMSP1(19) possessed inhibitory epitopes but induced anti-MSP1 Abs that were not inhibitory suggests that although the T-epitope(s) produced by immunization with YMSP1(19) could provide help for Ab production, it did not induce an effective inhibitory Ab response. We hypothesize that the nature/specificity of T helper epitopes on MSP1 may be crucial in efficient induction of biologically relevant and/or protective Abs.
This article has been cited by other articles:
![]() |
D. I. Stanisic, L. B. Martin, X. Q. Liu, D. Jackson, J. Cooper, and M. F. Good Analysis of Immunological Nonresponsiveness to the 19-Kilodalton Fragment of Merozoite Surface Protein 1 of Plasmodium yoelii: Rescue by Chemical Conjugation to Diphtheria Toxoid (DT) and Enhancement of Immunogenicity by Prior DT Vaccination Infect. Immun., October 1, 2003; 71(10): 5700 - 5713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wipasa, C. Hirunpetcharat, Y. Mahakunkijcharoen, H. Xu, S. Elliott, and M. F. Good Identification of T Cell Epitopes on the 33-kDa Fragment of Plasmodium yoelii Merozoite Surface Protein 1 and Their Antibody-Independent Protective Role in Immunity to Blood Stage Malaria J. Immunol., July 15, 2002; 169(2): 944 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Y. Pang, C. N. Hashimoto, L. Q. Tam, Z. Q. Meng, G. S. N. Hui, and W. K. K. Ho In Vivo Expression and Immunological Studies of the 42-Kilodalton Carboxyl-Terminal Processing Fragment of Plasmodium falciparum Merozoite Surface Protein 1 in the Baculovirus-Silkworm System Infect. Immun., June 1, 2002; 70(6): 2772 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. King, I. Malhotra, A. Wamachi, J. Kioko, P. Mungai, S. A. Wahab, D. Koech, P. Zimmerman, J. Ouma, and J. W. Kazura Acquired Immune Responses to Plasmodium falciparum Merozoite Surface Protein-1 in the Human Fetus J. Immunol., January 1, 2002; 168(1): 356 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Stowers, V. Cioce, R. L. Shimp, M. Lawson, G. Hui, O. Muratova, D. C. Kaslow, R. Robinson, C. A. Long, and L. H. Miller Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in an Aotus Challenge Trial Infect. Immun., March 1, 2001; 69(3): 1536 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Cavanagh, I. M. Elhassan, C. Roper, V. J. Robinson, H. Giha, A. A. Holder, L. Hviid, T. G. Theander, D. E. Arnot, and J. S. McBride A Longitudinal Study of Type-Specific Antibody Responses to Plasmodium falciparum Merozoite Surface Protein-1 in an Area of Unstable Malaria in Sudan J. Immunol., July 1, 1998; 161(1): 347 - 359. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |